Search

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it. The Food and Drug Administration warned on [...]

The move brings the total number of Johnson & Johnson doses made at the troubled plant and cleared by the F.D.A. to roughly 40 million. WASHINGTON -- Federal regulators on [...]

People ages 18 to 26 have been slow to get their shots, aides to President Biden said, ruling out the possibility of getting 70 percent of adults at least partly [...]

Byline: Sharon LaFraniere, Chris Hamby and Rebecca R. Ruiz Record profits warranted record bonuses. That was the recommendation in January by executives at the biotech firm Emergent BioSolutions. The board [...]

Record profits warranted record bonuses. That was the recommendation in January by executives at the biotech firm Emergent BioSolutions. The board of directors agreed, signing off on nearly $8 million [...]

The F.D.A. advised Johnson & Johnson on Friday that it should throw out the equivalent of 60 million doses produced at the Baltimore plant. A Baltimore factory that rendered useless [...]

The agency has not decided whether to allow a troubled vaccine factory in Baltimore to reopen. WASHINGTON -- Federal regulators said on Friday that millions of doses of Johnson & [...]

The White House's move is part of a nascent campaign to inoculate the world, and came as President Biden faced intense pressure to do more. WASHINGTON -- President Biden, under [...]

Byline: Noah Weiland, Sharon LaFraniere and Sheryl Gay Stolberg The vaccine maker has been seeking a new manufacturing partner since U.S. authorities decided that Emergent BioSolutions could not produce its [...]

The company has been seeking a new manufacturing partner since the federal authorities decided that Emergent BioSolutions could not produce its coronavirus vaccine. WASHINGTON -- The British-Swedish company AstraZeneca is [...]

Executives from Emergent, which ruined millions of coronavirus vaccine doses, divulged to Congress the scope of the regulatory review of its troubled Baltimore plant. WASHINGTON -- The chief executive of [...]

Millions of doses of Johnson & Johnson's Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution. WASHINGTON -- Quality-control problems [...]

President Biden, facing a slowing rate of vaccinations and a hope for near normalcy by Independence Day, said the government would shift from mass vaccination sites to local settings. WASHINGTON [...]

The U.S. vaccination campaign will soon expand to millions more people, but public health experts say the move raises complicated questions about supply and access. WASHINGTON -- The Food and [...]

Top federal health officials said in interviews this week that the number of rare blood clotting disorders in recipients of the Johnson & Johnson vaccine has remained small. WASHINGTON -- [...]

Last month, up to 15 million doses of Johnson & Johnson's vaccine had to be discarded at Emergent's factory in Baltimore. A new report says problems were not fully investigated [...]

Federal health officials called for a halt in the use of the company's coronavirus vaccine while they study serious illnesses that developed in six American women. WASHINGTON -- Injections of [...]

With deliveries from Johnson & Johnson set to fall 86 percent, a White House official warned that the vaccine would be scarce until a troubled Baltimore plant gains regulatory approval. [...]

An Operation Warp Speed report last June flagged staffing and quality control concerns at Emergent BioSolutions' factory in Baltimore. The troubled plant recently had to throw out up to 15 [...]

The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had [...]

A manufacturing subcontractor in Baltimore mixed ingredients from the coronavirus vaccines of Johnson & Johnson and AstraZeneca, setting back U.S. production of the ''one-and-done'' shot. WASHINGTON -- Workers at a [...]

The administration is stepping up the pace of vaccinations and expanding access to shots, but it remains in a race against a virus on the upswing. WASHINGTON -- President Biden, [...]

Byline: Sharon LaFraniere and Noah Weiland As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need [...]

As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need answers now about what to do [...]

According to federal officials, an independent panel of medical experts said the encouraging results announced on Monday might have relied on outdated information. Only hours after AstraZeneca announced encouraging news [...]

Trump administration officials grumble that they laid the groundwork for surging vaccinations, but some hard work in the trenches has helped pick up the pace of production. WASHINGTON -- When [...]

The pharmaceutical giant Merck & Co. agreed to help manufacture Johnson & Johnson's coronavirus vaccine, in a deal partly brokered by the White House. WASHINGTON -- President Biden said on [...]

The authorization of a third Covid-19 vaccine will bring millions more doses within days. But health officials worry that some people will see the vaccine as the inferior choice. WASHINGTON [...]

F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals. The coronavirus vaccine [...]

Byline: Sharon LaFraniere, Sheryl Gay Stolberg and Abby Goodnough Millions of doses of coronavirus vaccine are still sitting in freezers, allocated in excess to nursing homes or stockpiled for later [...]

Millions of doses of coronavirus vaccine are still sitting in freezers, allocated in excess to nursing homes or stockpiled for later use. Now states are claiming them. RICHMOND, Va. -- [...]

Moderna will ask federal regulators to increase the amount of coronavirus vaccine it can put in each vial by as much as 50 percent, potentially bolstering availability quickly. WASHINGTON -- [...]

The vaccine's efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases. Johnson & [...]

An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just [...]

Byline: Noah Weiland, Katie Thomas and Sharon LaFraniere After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine's formal [...]

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine's formal authorization language. The company charges by the dose. [...]

But with 200 million doses pledged for the first quarter of the year, some experts say President Biden's plan for 100 million shots in 100 days is far too modest. [...]

The U.S. needs J.&J.'s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract. Johnson & Johnson expects to release [...]

The N.I.H. and Moderna are examining whether doses of Moderna's coronavirus vaccine can be halved to double the supply, while scientists look for other ways to extend availability. WASHINGTON -- [...]

As the U.S. confronted a new wave of infection and death through the summer and fall, the president's approach to the pandemic came down to a single question: What would [...]

The company agreed to deliver the additional doses of its coronavirus vaccine by the end of July, helping address a looming shortage. The Trump administration and Pfizer announced a deal [...]

The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs [...]

One of the workers, who did not have a history of allergies, remained in the hospital on Wednesday night. Some reactions to the vaccine were also reported last week in [...]

The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the [...]

An initial shipment of about 2.9 million doses of the vaccine will be sent around the United States over the next week. The Food and Drug Administration authorized Pfizer's Covid-19 [...]

The blessing of these experts means that the agency will likely OK the vaccine's use, paving the way for health care workers to begin getting shots next week. Pfizer's Covid-19 [...]

Byline: Rebecca Robbins, Sharon LaFraniere, Noah Weiland, David D. Kirkpatrick and Benjamin Mueller The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused [...]

The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused it to fall behind in the U.S. On the afternoon of Sept. 8, [...]

President-elect Joseph R. Biden Jr.'s promise to shift the course of the pandemic in his first 100 days in office could run into vaccine production and procurement problems he will [...]

The pharmaceutical company offered the government a chance to lock in additional supplies before its vaccine was proved effective in clinical trials. WASHINGTON -- Before Pfizer's coronavirus vaccine was proved [...]